SCHEMBL25230406

SCHEMBL25230406

CS(=N)(=O)NCc1nn(-c2ccc(C(F)(F)F)cc2)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ TEAD1 P28347 1/20 0.40
▸ TEAD4 Q15561 1/20 0.40
▸ TEAD2 Q15562 1/20 0.40
▸ TEAD3 Q99594 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ RARG P13631 1/20 0.38
▸ RORC P51449 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ CCR1 P32246 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25281888 0.91 GRIA2 (0.45) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL30469100 0.91 GRIA2 (0.45) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL25278984 0.86 TEAD1 (0.43) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL25233252 0.83 GRIA2 (0.49) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL30469111 0.83 GRIA2 (0.49) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL25275654 0.82 NPY5R (0.39) NPY5RMAPTRAB9ACTDSP1L3MBTL1
SCHEMBL30469123 0.80 NPY5R (0.48) NPY5RLMNAPOLBEPHX2
SCHEMBL25274819 0.80 NPY5R (0.48) NPY5RLMNAPOLBEPHX2
SCHEMBL25274909 0.80 LMNA (0.50) NPY5RTEAD1TEAD4TEAD2TEAD3
SCHEMBL30469077 0.80 LMNA (0.50) NPY5RTEAD1TEAD4TEAD2TEAD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122782-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 — — WO disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 NPY5R 2669/4885MAPT 2347/4885RAB9A 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback